In Ethiopia, reference intervals in clinical laboratories are commonly based on results obtainedrnfor western populations or from test kit manufacturers. The present cross sectional study aimedrnto establish reference interval for CD4rn+rn T lymphocyte counts, in HIV sero-negative pregnantrnwomen attending antenatal care clinic at Yekatit 12 hospital. rnFlow cytometric analysis was performed to determine CD4rn+rn and total T lymphocyte counts.rnAccordingly gestational ages between 4 and 38weeks (n=120) were used. Reference valuesrnobtained were 310-1185 cells/µl for Absolute CD4rn+rn T cells count, 17.9-54.0% for CD4rn T cellsrnpercentage, 690-2540 cells/µl for absolute CD3rn+rn T cells count, 55-84% for CD3rnT cellsrnpercentage, 952-2985 cells/ µl for absolute CD45 rn+rn lymphocyte count. rnThe data revealed that CD4rnabsolute CD4rn+rn+rn T cell percentage was stable throughout the pregnancy period while rn T cell count varies between trimesters indicating that CD4rn+rn T cell percentagerncould be more reliable in the management of HIV infected pregnant women than the absoluternvalue. In conclusion, T lymphocyte populations in pregnant women were different from nonrnpregnant women. The clinical implication of these differences is the initiation of antiretroviralrntherapy (ART) in HIV infected pregnant women.